MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/acps.13432

Медицинская библиотека · Acta psychiatrica Scandinavica · 2022

Nitrous oxide for the treatment of psychiatric disorders: A systematic review of the clinical trial landscape.

Liu Helen, Kerzner Jaimie, Demchenko Ilya, Wijeysundera Duminda N, Kennedy Sidney H, Ladha Karim S, Bhat Venkat

СтатьяСистематический обзорПеревод пока не подготовлен

Аннотация

OBJECTIVE

To systematically review published research studies and ongoing clinical trials investigating nitrous oxide (N2 O) in psychiatric disorders, providing an up-to-date snapshot of the clinical research landscape.

METHODS

A comprehensive literature search was conducted for studies published until June 2021 using the OVID databases (MEDLINE, Embase, APA PsycInfo) and the clinical trial registries (ClinicalTrials.gov, ICTRP).

RESULTS

In total, five relevant published articles were identified, among which four investigated N2 O for depression. One single-dose randomized controlled trial (RCT) for treatment-resistant depression (TRD), one triple crossover RCT comparing 50% vs. 25% N2 O for TRD, and one repeated-dose RCT for major depressive disorder (MDD) suggest that N2 O has preliminary feasibility with rapid-acting effects on symptoms of depression. From the public registries, 10 relevant ongoing clinical trials were identified. They aim to explore the use of N2 O for MDD, post-traumatic stress disorder, bipolar disorder, obsessive-compulsive disorder, and suicidal ideation. To date, the typical treatment protocol parameters were a single session of 50% N2 O delivered for 60 min, although the concentration of 25% is also being explored. Projected enrolment numbers for ongoing trials (M = 55.0) were much higher than sample sizes for published studies (M = 13.0), suggesting that there potentially will be more large-scale RCTs published in the next few years.

CONCLUSION

Preliminary studies support the feasibility of administering N2 O for depression; however, appropriate blinding is a critical challenge. Larger-scale RCTs with repeated doses of N2 O and follow-up times beyond 1 month are needed to confirm the feasibility, therapeutic efficacy, and sustainability of response.

Для цитирования: Liu Helen, Kerzner Jaimie, Demchenko Ilya, Wijeysundera Duminda N, Kennedy Sidney H, Ladha Karim S, Bhat Venkat. Nitrous oxide for the treatment of psychiatric disorders: A systematic review of the clinical trial landscape.. Acta psychiatrica Scandinavica. 2022. DOI: 10.1111/acps.13432.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.